Pseudomonas aeruginosa infection causes lysosomal dysfunction in the cystic fibrosis bronchial epithelium
Infection and Immunity · 11.08.2026 · 94 (8)
DOI: 10.1128/iai.00347-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Immunity, erschienen am 11.08.2026. Verfasst von Emma Lea Matthews und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy & Critical Care Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, U…. Hauptthemen laut MEDLINE: Lysosomes, Cystic Fibrosis, Pseudomonas Infections, Pseudomonas aeruginosa. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Cystic fibrosis (CF) is a genetic disorder that causes chronic airway disease, leading to accelerated aging, inflammation, and susceptibility to opportunistic infections. Pseudomonas aeruginosa (PA) is prevalent in the CF lung, often multidrug-resistant, and affecting lung function decline, highlighting a need for alternative treatment strategies, such as host-directed therapeutics. The PA metabolite pyocyanin can induce senescence-associated β-galactosidase (SA-βgal), a lysosomal cell senescence marker. However, whether PA can induce cell senescence and therefore affect immune functions has not been studied. Using established airway epithelial culture models, we observed that PA infection increased SA-βgal activity and proinflammatory cytokines without increasing a comprehensive set of cell senescence markers. PA infection also resulted in lysosomal neutralization and decreased lysosome biogenesis, with the latter attenuated by rapamycin (RAPA), a senolytic and an established inhibitor of mTOR signaling. In conclusion, our study implies that PA infection does not induce cell senescence in the CF bronchial epithelium but disturbs lysosomal homeostasis, which can be attenuated by RAPA. These findings highlight lysosomal health as a promising therapeutic target in CF airways, especially as patients live longer yet remain susceptible to recurrent airway infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy & Critical Care Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Emma Lea Matthews, Megan R Kiedrowski, Stefanie Krick
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- National Heart, Lung, and Blood Institute
- National Institute of General Medical Sciences
Zitieren
APA
Matthews, E. L., Hirsch, M. J., Tsai, K. Y., McIntire-Ray, H. J., Rua, V. A., Morales, A. N., Jones, L. I., Barnes, J. W., Kiedrowski, M. R., & Krick, S. (2026). Pseudomonas aeruginosa infection causes lysosomal dysfunction in the cystic fibrosis bronchial epithelium. Infection and Immunity, 94(8). https://doi.org/10.1128/iai.00347-26
Vancouver
Matthews EL, Hirsch MJ, Tsai KY, McIntire-Ray HJ, Rua VA, Morales AN, et al. Pseudomonas aeruginosa infection causes lysosomal dysfunction in the cystic fibrosis bronchial epithelium. Infection and Immunity. 2026;94(8). doi:10.1128/iai.00347-26
BibTeX
@article{Matthews2026,
author = {Matthews, Emma Lea and Hirsch, Meghan June and Tsai, Kuen-You and McIntire-Ray, Hannah J and Rua, Viviana Acevedo and Morales, Angela N and Jones, Luke I and Barnes, Jarrod W and Kiedrowski, Megan R and Krick, Stefanie},
title = {Pseudomonas aeruginosa infection causes lysosomal dysfunction in the cystic fibrosis bronchial epithelium},
journal = {Infection and Immunity},
year = {2026},
volume = {94},
number = {8},
doi = {10.1128/iai.00347-26}
}
EUVIMED